Download the issuance: DM No. 2023-0333 dated September 20, 2023
Provides the operational and procedural guidelines on the implementation of the CAF, in alignment with the provisions stipulated in DOH-DBM Joint Memorandum Circular No. 2023-0001. Applies to all recognized implementing CAF Access Sites: identified DOH Cancer and Supportive-Palliative Medicines Access Program (CSPMAP) facilities; selected DOH hospitals designated as Cancer Specialty Centers; and other health facilities providing cancer services that are compliant to the minimum criteria set by the DOH to be access sites for the CAF.
Address further inquiries about this issuance to the DOH's Disease Prevention and Control Bureau.
See also: DOH-DBM JMC No. 2023-0001